<{$news["createtime"]|date_format:"%Y-%m-%d %H:%M"}>
智通財(cái)經(jīng)網(wǎng)
1.3w閱讀
2025-07-16 10:32
中金發(fā)布研報(bào)稱,隨著行業(yè)需求回暖、AI戰(zhàn)略聚焦,醫(yī)渡科技(02158)有望推動(dòng)AI解決方案在醫(yī)療行業(yè)的扎實(shí)落地,并支撐自身業(yè)績(jī)的穩(wěn)健增長(zhǎng)。保持其2026財(cái)年的收入和歸母凈利潤(rùn)預(yù)測(cè)基本不變;引入2027財(cái)年業(yè)績(jī)預(yù)測(cè):預(yù)計(jì)收入為8.7億元,預(yù)計(jì)歸母凈利潤(rùn)為411萬(wàn)元,維持跑贏行業(yè)評(píng)級(jí)。
報(bào)告指,2025財(cái)年,醫(yī)渡科技錄得收入7.1億元,其中,大數(shù)據(jù)平臺(tái)和解決方案業(yè)務(wù)收入同比增長(zhǎng)10.3%至3.5億元,醫(yī)院和監(jiān)管機(jī)構(gòu)客戶數(shù)分別達(dá)110名和44名。="white-space:normal;word-spacing:0px;text-transform:none;color:rgb(64,64,64);orphans:2;widows:2;letter-spacing:normal;background-color:rgb(255,255,255);text-indent:0px;-webkit-text-stroke-width:0px;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial'>=ds-markdown-paragraphstyle='white-space:normal;word-spacing:0px;text-transform:none;color:rgb(64,64,64);orphans:2;widows:2;letter-spacing:normal;background-color:rgb(255,255,255);text-indent:0px;-webkit-text-stroke-width:0px;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial'>展望未來(lái),隨著行業(yè)環(huán)境逐步回暖、核心產(chǎn)品獲更多客戶認(rèn)可,該行認(rèn)為公司或有望實(shí)現(xiàn)穩(wěn)健的收入增長(zhǎng)。=apple-interchange-newline>=ds-markdown-paragraphstyle='white-space:normal;word-spacing:0px;text-transform:none;color:rgb(64,64,64);orphans:2;widows:2;letter-spacing:normal;background-color:rgb(255,255,255);text-indent:0px;-webkit-text-stroke-width:0px;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial'>="white-space:normal;word-spacing:0px;text-transform:none;color:rgb(64,64,64);orphans:2;widows:2;letter-spacing:normal;background-color:rgb(255,255,255);text-indent:0px;-webkit-text-stroke-width:0px;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial'>=ds-markdown-paragraphstyle='white-space:normal;word-spacing:0px;text-transform:none;color:rgb(64,64,64);orphans:2;widows:2;letter-spacing:normal;background-color:rgb(255,255,255);text-indent:0px;-webkit-text-stroke-width:0px;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial'>="white-space:normal;word-spacing:0px;text-transform:none;color:rgb(64,64,64);orphans:2;widows:2;letter-spacing:normal;background-color:rgb(255,255,255);text-indent:0px;-webkit-text-stroke-width:0px;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial'>=ds-markdown-paragraphstyle='white-space:normal;word-spacing:0px;text-transform:none;color:rgb(64,64,64);orphans:2;widows:2;letter-spacing:normal;background-color:rgb(255,255,255);text-indent:0px;-webkit-text-stroke-width:0px;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial'>
目前,醫(yī)渡科技持續(xù)深化自研醫(yī)療垂域大模型的技術(shù)研發(fā)與場(chǎng)景賦能,AI中臺(tái)和EVWA數(shù)據(jù)中臺(tái)已分別迭代至2.0和5.0版本,同時(shí)公司也基于自研大模型升級(jí)推出了針對(duì)院管需求的“云析智管”平臺(tái)和針對(duì)科研需求的“云析智研”平臺(tái)。AI中臺(tái)具備數(shù)據(jù)治理、模型訓(xùn)練、智能體開發(fā)等能力,可支持智能病歷生成、臨床決策輔助、科研服務(wù)等多種場(chǎng)景。=ds-markdown-paragraphstyle='white-space:normal;word-spacing:0px;text-transform:none;color:rgb(64,64,64);orphans:2;widows:2;letter-spacing:normal;background-color:rgb(255,255,255);text-indent:0px;-webkit-text-stroke-width:0px;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial'>
重要提示:本文僅代表作者個(gè)人觀點(diǎn),并不代表樂(lè)居財(cái)經(jīng)立場(chǎng)。 本文著作權(quán),歸樂(lè)居財(cái)經(jīng)所有。未經(jīng)允許,任何單位或個(gè)人不得在任何公開傳播平臺(tái)上使用本文內(nèi)容;經(jīng)允許進(jìn)行轉(zhuǎn)載或引用時(shí),請(qǐng)注明來(lái)源。聯(lián)系請(qǐng)發(fā)郵件至ljcj@leju.com,或點(diǎn)擊【聯(lián)系客服】